Legis Daily

Chronic Kidney Disease Improvement in Research and Treatment Act

USA116th CongressHR-3912| House 
| Updated: 7/24/2019
John Lewis

John Lewis

Democratic Representative

Georgia

Cosponsors (5)
Barbara Lee (Democratic)Donald M. Payne (Democratic)Brian K. Fitzpatrick (Republican)Grace Meng (Democratic)Vern Buchanan (Republican)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Chronic Kidney Disease Improvement in Research and Treatment Act This bill expands, establishes, and otherwise modifies requirements under Medicare and other health care programs relating to individuals with end-stage renal disease (ESRD). Among other things, the bill expands the scope of the National Health Service Corps to specifically include kidney disease specialists, modifies payments under the Medicare ESRD program to exclude certain adjustment factors (e.g., comorbidities), authorizes incentive payments for renal dialysis facilities that exceed performance standards under the Medicare ESRD program, and expands guaranteed issue rights with respect to Medigap policies (Medicare supplemental health insurance policies) to all ESRD beneficiaries.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 23, 2019

Latest Companion Bill Action

S 116-1676
Introduced in Senate
Jul 23, 2019
Introduced in House
Jul 23, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 23, 2019
Referred to the Subcommittee on Health.
Jul 24, 2019
Referred to the Subcommittee on Health.
  • May 23, 2019

    Latest Companion Bill Action

    S 116-1676
    Introduced in Senate


  • July 23, 2019
    Introduced in House


  • July 23, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • July 23, 2019
    Referred to the Subcommittee on Health.


  • July 24, 2019
    Referred to the Subcommittee on Health.

Health

Related Bills

  • S 116-1676: Chronic Kidney Disease Improvement in Research and Treatment Act of 2019
  • HR 116-8181: Jack Reynold’s Memory MediGap Expansion
Administrative law and regulatory proceduresAgingCongressional oversightDebt collectionDepartment of Health and Human ServicesDigestive and metabolic diseasesDrug therapyGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth facilities and institutionsHealth information and medical recordsHealth personnelHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHospital careLong-term, rehabilitative, and terminal careMedical educationMedical researchMedicareNational and community servicePerformance measurementStudent aid and college costs

Chronic Kidney Disease Improvement in Research and Treatment Act

USA116th CongressHR-3912| House 
| Updated: 7/24/2019
Chronic Kidney Disease Improvement in Research and Treatment Act This bill expands, establishes, and otherwise modifies requirements under Medicare and other health care programs relating to individuals with end-stage renal disease (ESRD). Among other things, the bill expands the scope of the National Health Service Corps to specifically include kidney disease specialists, modifies payments under the Medicare ESRD program to exclude certain adjustment factors (e.g., comorbidities), authorizes incentive payments for renal dialysis facilities that exceed performance standards under the Medicare ESRD program, and expands guaranteed issue rights with respect to Medigap policies (Medicare supplemental health insurance policies) to all ESRD beneficiaries.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 23, 2019

Latest Companion Bill Action

S 116-1676
Introduced in Senate
Jul 23, 2019
Introduced in House
Jul 23, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 23, 2019
Referred to the Subcommittee on Health.
Jul 24, 2019
Referred to the Subcommittee on Health.
  • May 23, 2019

    Latest Companion Bill Action

    S 116-1676
    Introduced in Senate


  • July 23, 2019
    Introduced in House


  • July 23, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • July 23, 2019
    Referred to the Subcommittee on Health.


  • July 24, 2019
    Referred to the Subcommittee on Health.
John Lewis

John Lewis

Democratic Representative

Georgia

Cosponsors (5)
Barbara Lee (Democratic)Donald M. Payne (Democratic)Brian K. Fitzpatrick (Republican)Grace Meng (Democratic)Vern Buchanan (Republican)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 116-1676: Chronic Kidney Disease Improvement in Research and Treatment Act of 2019
  • HR 116-8181: Jack Reynold’s Memory MediGap Expansion
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresAgingCongressional oversightDebt collectionDepartment of Health and Human ServicesDigestive and metabolic diseasesDrug therapyGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth facilities and institutionsHealth information and medical recordsHealth personnelHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHospital careLong-term, rehabilitative, and terminal careMedical educationMedical researchMedicareNational and community servicePerformance measurementStudent aid and college costs